Amgen

Neuroendocrine Tumors (NETs) Unraveling the Mystery of a Complex Cancer

Oct 30, 2024

Neuroendocrine Tumors (NETs): Unraveling the Mystery of a Complex Cancer

stelara-biosimilar-wezlana

Dec 01, 2023

Could Amgen’s Biosimilar Wezlana Pose a Challenge to Johnson & Johnson’s Stelara

Pharma News for Amgen, Anaptys, Sanofi, Boehringer

Oct 10, 2023

Amgen to Acquire Horizon Therapeutics; Sanofi and Teva Announce Collaboration; Boehringer Obesity Drug Trial Update; FDA Places Partial Clinical Hold on IND for Lacutamab in CTCL/PTCL; Anaptys Announces Phase 3 Clinical Trial Results of Imsidolimab; Orphan Drug Designation to GC Biopharma’s GC1126A

Rare diseases challenges | Rare diseases clinical trials, incidence, and funding

Feb 15, 2021

The Paradox of Rare: Chalking out Challenges in the Rare Disease Market

Small Cell Lung Cancer Market | SCLC Market

Jul 03, 2020

Small Cell Lung Cancer Market Booms with an Influx of Companies and Robust Pipeline

pharma-news

Jun 09, 2020

Alnylam’s lumasiran results; AZ’s oncology drug; Astellas Roxadustat; Evotec’s partnership with ABL

Pharma News

Jan 16, 2020

Thumbs down to NKTR-181, Lilly expands its insulin armamentarium

Pharma News

Nov 05, 2019

AstraZeneca tops the first Pharma Invention Index; Amgen to buy 20.5% stake in a Chinese pharmaceutical, BeiGene; Ascentage, Henlius collaborates to develop a Combination therapy

Cluster headache

Jun 07, 2019

Lilly overtakes rivals with its Cluster Headache approval

World Pharma News

May 23, 2019

The Business Cocktail

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper